# Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19

> **NCT04325061** · PHASE4 · TERMINATED · sponsor: **Dr. Negrin University Hospital** · enrollment: 19 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome Caused by COVID-19

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04325061
- **Lead sponsor:** Dr. Negrin University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-03
- **Primary completion:** 2020-06-19
- **Final completion:** 2020-06-19
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2021-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325061, "Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04325061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*